SIRT1 and cancer: In cancer, DYRK3 was proposed to act in parallel with DYRK1A to promote cell survival under stressful conditions by phosphorylating nicotinamide adenosine dinucleotide (NAD)-dependent deacetylase SIRT1 [38].